Zobrazeno 1 - 10
of 17
pro vyhledávání: '"M. M. Zafranskaya"'
Autor:
D. B. Nizheharodava, N. A. Marozava, G. I. Ivanchyk, S. S. Kulinich, J. V. Kolyadich, M. M. Zafranskaya
Publikováno v:
Медицинская иммунология, Vol 26, Iss 5, Pp 933-940 (2024)
The subpopulations of dendritic cells and their functional potential determined by endogenous interferon status in tumor microenvironment is an important stage in tumor-specific T-lymphocytes effector reactions development. In this regard, understand
Externí odkaz:
https://doaj.org/article/29c6e0a5ec3c44a9ba41db6cc5def2cc
Publikováno v:
Медицинская иммунология, Vol 25, Iss 6, Pp 1343-1352 (2023)
The immunological factors can play an important role as predictive and prognostic biomarkers in oncopathology. Recently, non-conventional innate-like γδT-lymphocytes have received a lot of attention as a promising effector cell population for cance
Externí odkaz:
https://doaj.org/article/e6c76eae0da1469fa55e052d6a064fc2
Autor:
D. B. Nizheharodava, A. Ch. Shuleika, A. M. Starastsin, M. I. Vanslau, G. I. Ivanchyk, A. V. Vialichka, M. M. Zafranskaya
Publikováno v:
Медицинская иммунология, Vol 25, Iss 5, Pp 1103-1110 (2023)
Intraepithelial lymphocytes (IEL) play a critical role in maintaining the immune balance of the gut and provide the first line of mucosal defense against luminal antigens as well as rapidly respond to epithelial injury. Recently, IEL have received a
Externí odkaz:
https://doaj.org/article/41ddf868ceb744d8b42c04cd2b40dc0d
Publikováno v:
Медицинская иммунология, Vol 25, Iss 2, Pp 309-318 (2023)
Currently, no drugs have been identified that could slow progression of chronic obstructive pulmonary disease (COPD), or have a significant impact on patient mortality. Therefore, research continues aimed at studying the mechanisms of COPD developmen
Externí odkaz:
https://doaj.org/article/047d1c323a7748abb86a0067192d14e1
Publikováno v:
Медицинская иммунология, Vol 22, Iss 6, Pp 1131-1140 (2021)
Mechanisms of recognition and effector responses of immune system upon initiation and maintenance of immune-mediated inflammation and tissue damage in inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis (UC), have been act
Externí odkaz:
https://doaj.org/article/f647665565c64ca58ec76f30a7defcbf
Autor:
M. M. Zafranskaya, D. B. Nizhegorodova
Publikováno v:
Медицинская иммунология, Vol 19, Iss 6, Pp 683-704 (2017)
The ability of mesenchymal stem cells (MSC) to influence the regulatory/suppressive effect in the autoimmune process and promote remyelination allows to consider them a new method of multiple sclerosis (MS) therapy, by means of modifying the disease
Externí odkaz:
https://doaj.org/article/09a65d974296442c83c4670d465e5c55
Autor:
D. B. Nizhegorodova, M. M. Zafranskaya
Publikováno v:
Медицинская иммунология, Vol 11, Iss 2-3, Pp 115-130 (2014)
Abstract. γδТ lymphocytes represent a poorly investigated heterogeneous population of T cells that are found, predominantly, in mucosal structures, and express common characteristics of innate and acquired immunity. Lack of both antigen processing
Externí odkaz:
https://doaj.org/article/776aa16e703a441fa4da32342fcdd211
Autor:
M. M. Zafranskaya, D. B. Nizhegorodova, M. Yu. Yurkevich, S. S. Bagatka, H. I. Ivanchyk, Yana M. Motuzova, A. S. Fedulov
Publikováno v:
Медицинская иммунология, Vol 13, Iss 2-3, Pp 237-246 (2014)
Abstract. We investigated the ability of autologous/allogeneic mesenchymal stem cells (MSC) from early passages, derived from bone marrow of patients with multiple sclerosis, to inhibit mitogen/myelin-induced proliferation of memory T cells. It was s
Externí odkaz:
https://doaj.org/article/7f19bed10f4d40aa8b8a8c89bdb016b4
Publikováno v:
Medical Immunology (Russia). 25:309-318
Currently, no drugs have been identified that could slow progression of chronic obstructive pulmonary disease (COPD), or have a significant impact on patient mortality. Therefore, research continues aimed at studying the mechanisms of COPD developmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::adc4c757a6bb9c34cb1fe3240cb8e675
https://doi.org/10.15789/1563-0625-eoa-2581
https://doi.org/10.15789/1563-0625-eoa-2581
Autor:
A G, Kadushkin, A D, Tahanovich, L V, Movchan, M M, Zafranskaya, V V, Dziadzichkina, T V, Shman
Publikováno v:
Biomeditsinskaya Khimiya. 68:134-143
To date, there are no drugs that can prevent progressive destruction of lung tissue and small airway fibrosis in patients with chronic obstructive pulmonary disease (COPD). Therefore, molecular mechanisms of this disease are being studied. The aim of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eadff54c0d02a7fca987d64d23a2e9f8
https://doi.org/10.18097/pbmc20226802134
https://doi.org/10.18097/pbmc20226802134